Aggressive multiple sclerosis (2): Treatment

for the 2018 ECTRIMS Focused Workshop Group, Georgina Arrambide, Ellen Iacobaeus, Maria Pia Amato, Tobias Derfuss, Sandra Vukusic, Bernhard Hemmer, Lou Brundin, Mar Tintore

Research output: Contribution to journalReview articlepeer-review


The natural history of multiple sclerosis (MS) is highly heterogeneous. A subgroup of patients has what might be termed aggressive MS. These patients may have frequent, severe relapses with incomplete recovery and are at risk of developing greater and permanent disability at the earlier stages of the disease. Their therapeutic window of opportunity may be narrow, and while it is generally considered that they will benefit from starting early with a highly efficacious treatment, a unified definition of aggressive MS does not exist and data on its treatment are largely lacking. Based on discussions at an international focused workshop sponsored by the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), we review our current knowledge about treatment of individuals with aggressive MS. We analyse the available evidence, identify gaps in knowledge and suggest future research needed to fill those gaps. A companion paper details the difficulties in developing a consensus about what defines aggressive MS.

Original languageEnglish
JournalMultiple Sclerosis Journal
Publication statusE-pub ahead of print - Jun 2020


  • Aggressive
  • disability
  • highly active
  • multiple sclerosis
  • relapsing–remitting
  • treatment response

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Aggressive multiple sclerosis (2): Treatment'. Together they form a unique fingerprint.

Cite this